FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2091330484> ?p ?o ?g. }

• W2091330484 endingPage "1078" @default.
• W2091330484 startingPage "1073" @default.
• W2091330484 abstract "BACKGROUND High-dose melphalan (HDM) is now a standard treatment for multiple myeloma (MM). Stem cell transplants are fast evolving as an alternative to bone marrow transplants because they are less traumatic and easier to perform. A study was undertaken to test if whole blood harvested after mobilizing peripheral blood stem cells with granulocyte-colony stimulating factor (G-CSF) reinfused as such (without stem cells being processed or concentrated through a cell separator) for rescue after HDM (dose 140–180 mg/m2) in MM accelerates hematopoietic recovery. METHODS Eight consecutive patients with MM were given HDM after receiving 4–5 courses of infusional vincristine, doxorubicin, and dexamethasone (VAD) chemotherapy. Approximately 6 weeks after the last course of chemotherapy, at the start of the procedure, G-CSF (Neupogen) was given at a dose of 10 μg/kg subcutaneously daily for 4 days to mobilize stem cells. All of the patients had brisk leukocytosis (18.4–64.6 × 109/L). On day 0 (fifth day after G-CSF), 1 L of blood was removed by phlebotomy and kept at room temperature for 24 hours. This was followed by a rapid intravenous (i.v.) bolus of melphalan at a dose of 140 mg/m2 in the first three patients, 155 mg/m2 in the 4th, 170 mg/m2 in the 5th, and 180 mg/m2 in the 6th, 7th, and 8th patients, applies to all patients along with hydration and diuresis. Twenty-four hours later, 1 L of blood previously removed was transfused back to the patient without any processing through the cell separator. The numbers of mononuclear cells reinfused was between 0.76 and 3.2 × 108/kg (mean: 1.82 × 108/kg). The number of CD 34+ cells infused in 4 patients ranged from 1.9 to 2.8 × 106/kg (mean: 2.35 × 106/kg). G-CSF was restarted on day 2 at a dose of 5 μg/kg and given daily until the granulocyte count was 0.5 × 109/L or more for 3 consecutive days. Antibiotics were given whenever a patient developed pyrexia. Platelets were transfused if below 20 × 109/L or for incidences of overt bleeding. RESULTS Granulocyte counts touched 0 between Days 6 and 10, lasting for an average of 3.4 days. Duration of granulocyte count below 0.5 × 109/L was 6.5 days (range: 5–9), and these rose to 1.0 or more × 109/L by Day 13.7 (range: 13–16). The number of platelet transfusions given per patient was 2.5 (range: 0–4). Intravenous antibiotics were used for 9 days (range: 4–12), and patients were discharged on Day 19 (range: 16–22). Follow-up ranged from 45 to 380 days. CONCLUSIONS Hematopoietic recovery was rapid in all patients, including those who received doses of melphalan higher than 140 mg/m2. This resulted in less need for platelet transfusions or antibiotics, and hospitalization was short. Our results are historically similar to conventional peripheral blood stem cell transplants but much better than autologous bone marrow transplants, indicating that whole blood after G-CSF provided sufficient progenitor cells for early engraftment. The procedure is less labor intensive insofar as it does not require separation and concentration of stem cells. It has the potential of becoming an alternative to autologous marrow and peripheral blood stem cell transplantation in patients with MM. Cancer 1996;77:1073-8." @default.
• W2091330484 created "2016-06-24" @default.
• W2091330484 creator A5012410926 @default.
• W2091330484 creator A5050719677 @default.
• W2091330484 creator A5050913926 @default.
• W2091330484 creator A5072952828 @default.
• W2091330484 date "1996-03-15" @default.
• W2091330484 modified "2023-09-24" @default.
• W2091330484 title "Whole blood harvested after granulocyte-colony stimulating factor (Neupogen) mobilization, and reinfused unprocessed after high-dose melphalan treatment, accelerates hematopoietic recovery in patients with multiple myeloma" @default.
• W2091330484 cites W1256794680 @default.
• W2091330484 cites W1526986700 @default.
• W2091330484 cites W1541496572 @default.
• W2091330484 cites W1791616244 @default.
• W2091330484 cites W1840931904 @default.
• W2091330484 cites W1847164289 @default.
• W2091330484 cites W1851257302 @default.
• W2091330484 cites W1964073968 @default.
• W2091330484 cites W2028103454 @default.
• W2091330484 cites W2050149613 @default.
• W2091330484 cites W2093633247 @default.
• W2091330484 cites W2138917119 @default.
• W2091330484 cites W2232102497 @default.
• W2091330484 cites W4251517065 @default.
• W2091330484 cites W4255444424 @default.
• W2091330484 doi "https://doi.org/10.1002/(sici)1097-0142(19960315)77:6<1073::aid-cncr11>3.0.co;2-z" @default.
• W2091330484 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8635126" @default.
• W2091330484 hasPublicationYear "1996" @default.
• W2091330484 type Work @default.
• W2091330484 sameAs 2091330484 @default.
• W2091330484 citedByCount "7" @default.
• W2091330484 crossrefType "journal-article" @default.
• W2091330484 hasAuthorship W2091330484A5012410926 @default.
• W2091330484 hasAuthorship W2091330484A5050719677 @default.
• W2091330484 hasAuthorship W2091330484A5050913926 @default.
• W2091330484 hasAuthorship W2091330484A5072952828 @default.
• W2091330484 hasConcept C10205521 @default.
• W2091330484 hasConcept C109159458 @default.
• W2091330484 hasConcept C126322002 @default.
• W2091330484 hasConcept C126894567 @default.
• W2091330484 hasConcept C141071460 @default.
• W2091330484 hasConcept C2776364478 @default.
• W2091330484 hasConcept C2776694085 @default.
• W2091330484 hasConcept C2777371436 @default.
• W2091330484 hasConcept C2777767877 @default.
• W2091330484 hasConcept C2778684742 @default.
• W2091330484 hasConcept C2780007613 @default.
• W2091330484 hasConcept C28328180 @default.
• W2091330484 hasConcept C54355233 @default.
• W2091330484 hasConcept C71924100 @default.
• W2091330484 hasConcept C86803240 @default.
• W2091330484 hasConceptScore W2091330484C10205521 @default.
• W2091330484 hasConceptScore W2091330484C109159458 @default.
• W2091330484 hasConceptScore W2091330484C126322002 @default.
• W2091330484 hasConceptScore W2091330484C126894567 @default.
• W2091330484 hasConceptScore W2091330484C141071460 @default.
• W2091330484 hasConceptScore W2091330484C2776364478 @default.
• W2091330484 hasConceptScore W2091330484C2776694085 @default.
• W2091330484 hasConceptScore W2091330484C2777371436 @default.
• W2091330484 hasConceptScore W2091330484C2777767877 @default.
• W2091330484 hasConceptScore W2091330484C2778684742 @default.
• W2091330484 hasConceptScore W2091330484C2780007613 @default.
• W2091330484 hasConceptScore W2091330484C28328180 @default.
• W2091330484 hasConceptScore W2091330484C54355233 @default.
• W2091330484 hasConceptScore W2091330484C71924100 @default.
• W2091330484 hasConceptScore W2091330484C86803240 @default.
• W2091330484 hasIssue "6" @default.
• W2091330484 hasLocation W20913304841 @default.
• W2091330484 hasLocation W20913304842 @default.
• W2091330484 hasOpenAccess W2091330484 @default.
• W2091330484 hasPrimaryLocation W20913304841 @default.
• W2091330484 hasRelatedWork W2003367269 @default.
• W2091330484 hasRelatedWork W2007757074 @default.
• W2091330484 hasRelatedWork W2011495040 @default.
• W2091330484 hasRelatedWork W2018148419 @default.
• W2091330484 hasRelatedWork W2035629708 @default.
• W2091330484 hasRelatedWork W2088705276 @default.
• W2091330484 hasRelatedWork W2548609368 @default.
• W2091330484 hasRelatedWork W2580876829 @default.
• W2091330484 hasRelatedWork W3176989103 @default.
• W2091330484 hasRelatedWork W4306321279 @default.
• W2091330484 hasVolume "77" @default.
• W2091330484 isParatext "false" @default.
• W2091330484 isRetracted "false" @default.
• W2091330484 magId "2091330484" @default.
• W2091330484 workType "article" @default.